avatar for Richard Dennett

Richard Dennett

Senior Director Regulatory Affairs CMC
Richard Dennett heads the Regulatory Affairs CMC activities at PPD and provides expertise, technical guidance & leadership for global CMC regulatory strategy. He additionally chairs PPD’s Advanced Therapy Forum. Richard has held several strategic product development roles including Regulatory & Technical CMC strategy, cGMP compliance, ‘hands on’ start-finish product development though to EU/US market approval for a complex biopharmaceutical, contract development manufacture across multiple product classes. He was company co-founder of Eden Biodesign (Allergan) which realised and commercially operated the former UK National Biomanufacturing Centre as a successful CMO. Richard obtained his degree and PhD in Biochemistry at Liverpool UK

My Speakers Sessions

Monday, June 15

10:15am EDT